VEGFA and Blindness: Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness in elderly people [1, 2], and the advent of anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment of nAMD [3–5].